|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 577.6 PKR | +0.50% |
|
+5.41% | +25.51% |
Abbott Laboratories (Pakistan) Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was PKR 49,257.72 million compared to PKR 42,569.86 million a year ago. Net income was PKR 3,004.19 million compared to PKR 5,967.06 million a year ago.
Basic earnings per share from continuing operations was PKR 30.69 compared to PKR 60.95 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +25.51% | 203M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
ABBOTT LABORATORIES (PAKISTAN) LIMITED 
